378 related articles for article (PubMed ID: 10855035)
1. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
2. Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis.
Noisakran S; Campbell IL; Carr DJ
J Immunol; 1999 Apr; 162(7):4184-90. PubMed ID: 10201945
[TBL] [Abstract][Full Text] [Related]
3. ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-alpha1 transgene efficacy.
Noisakran S; Härle P; Carr DJ
Virology; 2001 Apr; 283(1):69-77. PubMed ID: 11312663
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
5. Astrocyte-targeted expression of IFN-alpha1 protects mice from acute ocular herpes simplex virus type 1 infection.
Carr DJ; Veress LA; Noisakran S; Campbell IL
J Immunol; 1998 Nov; 161(9):4859-65. PubMed ID: 9794419
[TBL] [Abstract][Full Text] [Related]
6. Innate and acquired immunity to herpes simplex virus type 1.
Halford WP; Veress LA; Gebhardt BM; Carr DJ
Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits.
O'Brien WJ; Tsao LS; Taylor JL
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1847-53. PubMed ID: 9727407
[TBL] [Abstract][Full Text] [Related]
8. Topical application of the cornea post-infection with plasmid DNA encoding interferon-alpha1 but not recombinant interferon-alphaA reduces herpes simplex virus type 1-induced mortality in mice.
Noisakran S; Carr DJ
J Neuroimmunol; 2001 Dec; 121(1-2):49-58. PubMed ID: 11730939
[TBL] [Abstract][Full Text] [Related]
9. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA encoding IFN-alpha 1 antagonizes herpes simplex virus type 1 ocular infection through CD4+ and CD8+ T lymphocytes.
Noisakran S; Carr DJ
J Immunol; 2000 Jun; 164(12):6435-43. PubMed ID: 10843699
[TBL] [Abstract][Full Text] [Related]
11. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
[TBL] [Abstract][Full Text] [Related]
12. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1.
Halford WP; Gebhardt BM; Carr DJ
J Immunol; 1996 Oct; 157(8):3542-9. PubMed ID: 8871654
[TBL] [Abstract][Full Text] [Related]
13. A replication competent HSV-1(McKrae) with a mutation in the amino-terminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea infection.
Saied AA; Chouljenko VN; Subramanian R; Kousoulas KG
Curr Eye Res; 2014 Jun; 39(6):596-603. PubMed ID: 24401006
[TBL] [Abstract][Full Text] [Related]
14. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
15. A plasmid construct encoding murine interferon beta antagonizes the replication of herpes simplex virus type I in vitro and in vivo.
Cui B; Carr DJ
J Neuroimmunol; 2000 Aug; 108(1-2):92-102. PubMed ID: 10900342
[TBL] [Abstract][Full Text] [Related]
16. Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.
Kovacs SK; Tiwari V; Prandovszky E; Dosa S; Bacsa S; Valyi-Nagy K; Shukla D; Valyi-Nagy T
Curr Eye Res; 2009 Oct; 34(10):896-904. PubMed ID: 19895317
[TBL] [Abstract][Full Text] [Related]
17. Androstenediol antagonizes herpes simplex virus type 1-induced encephalitis through the augmentation of type I IFN production.
Daigle J; Carr DJ
J Immunol; 1998 Mar; 160(6):3060-6. PubMed ID: 9510212
[TBL] [Abstract][Full Text] [Related]
18. The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon.
Carr DJ; Noisakran S
J Virol; 2002 Sep; 76(18):9398-406. PubMed ID: 12186922
[TBL] [Abstract][Full Text] [Related]
19. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice.
Benencia F; Courrèges MC; Gamba G; Cavalieri H; Massouh EJ
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1277-84. PubMed ID: 11328740
[TBL] [Abstract][Full Text] [Related]
20. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]